- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00638521
Immune-cell Membrane Trafficking
December 10, 2013 updated by: Joseph Cuschieri, University of Washington
Trauma and Sepsis Induced Changes in Immune-cell Membrane Receptor Trafficking
Organ failure following trauma is a leading cause of morbidity and mortality.
It appears that the development of organ failure is a direct result of an altered immune response.
This altered response results in the production of circulating factors in the blood that causes direct injury to the injured patients' organs.
The mechanism in which this altered immune response occurs is unknown.
Based on work we have performed in our laboratory, we believe that this response is initiated on the cell membrane of particular immune cells known as macrophages.
Although the cell membrane may appear uniform, it is not.
The membrane is composed of specific segments that allow proteins to associate with each other forming receptors that are required for immune cell activation.
These specific membrane components are composed of various lipids and cholesterol, and have been termed lipid rafts.
Based on our laboratory work it appears that these lipid rafts can be altered following injury.
In particular both the lipid and protein content within these raft segments may be altered allowing immune cells to become active leading to the production of factors that directly injure normal cells and organs.
Thus, we plan to examine if these laboratory findings can be seen in patients suffering from trauma who develop clinical organ failure at Harborview Medical Center.
If this is accomplished, this data will lead to the development of both prognostic and therapeutic interventions for the optimal care of injured patient
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
213
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98104
- Harborview Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Inclusion criteria:
Description
Inclusion Criteria:
- age 18 years or older, blunt or penetrating trauma and
- one or more of the following: systolic blood pressure less than 90 mmHg at the scene or within one hour of arrival to the Emergency Department, 2) base deficit ≥ -6 within one hour of admission, 3) ISS greater than 25, or 4) more than 6 units of blood transfused in the first 12 hours.-
Exclusion Criteria:
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Assessment of protein and lipid changes in immune cells following severe injury
Time Frame: 5/08 to 8/12
|
5/08 to 8/12
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Assessment of severe injury effect on plasma and cellular lipid content
Time Frame: 5/08 to 8/12
|
5/08 to 8/12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Joseph Cuschieri, MD, University of Washington
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2008
Primary Completion (Actual)
August 1, 2012
Study Completion (Actual)
June 1, 2013
Study Registration Dates
First Submitted
March 12, 2008
First Submitted That Met QC Criteria
March 18, 2008
First Posted (Estimate)
March 19, 2008
Study Record Updates
Last Update Posted (Estimate)
December 11, 2013
Last Update Submitted That Met QC Criteria
December 10, 2013
Last Verified
December 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 31888-A
- GM078054-01 (Other Identifier: National Institute of General Medical Sciences (NIGMS))
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Severe Trauma
-
Second Affiliated Hospital, School of Medicine,...Completed
-
Hospices Civils de LyonCompleted
-
University Hospital Center of MartiniqueNot yet recruiting
-
Assiut UniversityNot yet recruitingSevere Head Trauma
-
Abela Pharmaceuticals, Inc.Ohio State University; University of California, Irvine; Dr. Mahajan's Hospital...UnknownSevere Head TraumaUnited States
-
Hospital Departamental de VillavicencioCooperative University of ColombiaCompletedTrauma | Severe Trauma | Polytrauma | Registries | Trauma Blunt | Penetrating WoundsColombia
-
University Hospital, GrenobleCompleted
-
Major Extremity Trauma Research ConsortiumCompletedSevere Orthopedic TraumaUnited States
-
Ataturk UniversityCompletedMalnutrition Severe | Trauma (Including Fractures) | Dialysis CatheterTurkey (Türkiye)
-
Università degli Studi dell'InsubriaUnknownSevere Brain TraumaItaly